119 related articles for article (PubMed ID: 8860838)
1. Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53.
Roth JA
Hum Gene Ther; 1996 May; 7(7):861-74. PubMed ID: 8860838
[No Abstract] [Full Text] [Related]
2. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
Roth JA
Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520
[No Abstract] [Full Text] [Related]
3. Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin.
Roth JA
Hum Gene Ther; 1996 May; 7(8):1013-30. PubMed ID: 8727511
[No Abstract] [Full Text] [Related]
4. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
[TBL] [Abstract][Full Text] [Related]
5. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA
Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene therapy for cancer.
Roth JA; Swisher SG; Meyn RE
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
[TBL] [Abstract][Full Text] [Related]
7. Viral and non-viral vectors for cancer gene therapy.
Cristiano RJ
Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
[TBL] [Abstract][Full Text] [Related]
10. Mutations in p53 cDNA sequence introduced by retroviral vector.
Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T
Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Roth JA; Nguyen D; Lawrence DD; Kemp BL; Carrasco CH; Ferson DZ; Hong WK; Komaki R; Lee JJ; Nesbitt JC; Pisters KM; Putnam JB; Schea R; Shin DM; Walsh GL; Dolormente MM; Han CI; Martin FD; Yen N; Xu K; Stephens LC; McDonnell TJ; Mukhopadhyay T; Cai D
Nat Med; 1996 Sep; 2(9):985-91. PubMed ID: 8782455
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
13. p53 Gene therapy for lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
[TBL] [Abstract][Full Text] [Related]
14. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
15. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M
Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro.
Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R
Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
Huang CL; Yokomise H; Miyatake A
Future Oncol; 2007 Feb; 3(1):83-93. PubMed ID: 17280505
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan].
Kagawa S; Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865
[TBL] [Abstract][Full Text] [Related]
19. CT-guided intratumoral gene therapy in non-small-cell lung cancer.
Kauczor HU; Schuler M; Heussel CP; von Weymarn A; Bongartz G; Rochlitz C; Huber C; Thelen M
Eur Radiol; 1999; 9(2):292-6. PubMed ID: 10101653
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy in lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2000 Jan; 2(1):64-70. PubMed ID: 11122826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
